Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1998052514) TREATMENT OF HEPATIC CIRRHOSIS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1998/052514 International Application No.: PCT/US1998/010505
Publication Date: 26.11.1998 International Filing Date: 22.05.1998
Chapter 2 Demand Filed: 22.10.1998
IPC:
A61K 31/505 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
495
having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505
Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Applicants:
HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT COMPANY LTD. [IL/IL]; Kiryat Hadassah 91120 Jerusalem, IL
AGRICULTURAL RESEARCH ORGANIZATION [IL/IL]; Ministry of Agriculture The Vocani Center 50250 Bet Dagan, IL
FRIEDMAN, Mark, M. [US/IL]; IL (TJ)
Inventors:
PINES, Mark; IL
NAGLER, Arnon; IL
Agent:
FRIEDMAN, Mark, M.; c/o Castorina, Anthony Suite 207 2001 Jefferson Davis Highway Arlington, VA 22202, US
Common
Representative:
FRIEDMAN, Mark, M.; c/o Castorina, Anthony Suite 207 2001 Jefferson Davis Highway Arlington, VA 22202, US
Priority Data:
08/862,38223.05.1997US
Title (EN) TREATMENT OF HEPATIC CIRRHOSIS
(FR) TRAITEMENT DE LA CIRRHOSE HEPATIQUE
Abstract:
(EN) A composition for treating hepatic fibrosis and hepatic cirrhosis, and methods of using and manufacturing the composition are provided. The composition includes a quinazolinone derivative, preferably Halofuginone.
(FR) L'invention concerne une composition permettant de traiter la fibrose hépatique ou la cirrhose hépatique, ainsi que des méthodes d'utilisation et des procédés de fabrication de ladite composition. La composition renferme un dérivé de quinazolinone, de préférence Halofuginone.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
KR1020010012838IL132848EP1014988JP2002515905 CN1265034CA2290502
AU1998076922